Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) investors cheer the news that the drug maker will acquire the U.
Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) announced the availability of once-daily YOSPRALA™, the only prescription fixed-dose combination of aspirin, an anti-platelet agent, and omeprazole, a proton …
Guggenheim analyst Louise Chen was out with a research note on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ), reiterating a Buy rating and price target of …
In a research report released Friday, Chardan Capital analyst Keay Nakae reiterated a Buy rating on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) with a …
Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) announced that the U.S.
Aralez Pharmaceuticals Inc (NASDAQ:ARLZ), a global specialty pharmaceutical company, announced that it acquired the U.S.
